Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

903
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
903
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Derangement and Vitamin Deficiencies.

Neuroimaging clinics of North America·2026
Same author

Metapneumovirus-associated necrotizing disseminated acute leukoencephalopathy.

Arquivos de neuro-psiquiatria·2026
Same author

Antineutrophil cytoplasmic antibody-associated pachymeningitis: a systematic review of clinical features, diagnosis and treatment outcomes.

Immunologic research·2026
Same author

A Novel TUBB2A Variant Causing Ataxia With Preserved Ambulation Into Adulthood.

American journal of medical genetics. Part A·2026
Same author

Choreiform Wilson's disease and a distinctive 7-Tesla magnetic resonance imaging finding.

Arquivos de neuro-psiquiatria·2026
Same author

Coronal Clival Cleft: Estimated Prevalence and Clinical Associations in a Pediatric Cohort.

AJNR. American journal of neuroradiology·2026
Same journal

Preface.

Handbook of clinical neurology·2026
Same journal

Foreword.

Handbook of clinical neurology·2026
Same journal

Fundus autofluorescence imaging.

Handbook of clinical neurology·2026
Same journal

The electroretinogram as a means to study the physiology of the retina.

Handbook of clinical neurology·2026
Same journal

Adaptive optics scanning light ophthalmoscopy.

Handbook of clinical neurology·2026
Same journal

Modeling the human retina in a dish: Advances and future directions.

Handbook of clinical neurology·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Isolation of Brain-infiltrating Leukocytes
06:44

Isolation of Brain-infiltrating Leukocytes

Published on: June 13, 2011

19.1K

Toxic leukoencephalopathies.

Gabriela Alencar Bandeira1, Leandro Tavares Lucato1

  • 1Neuroradiology Section, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil; Grupo Fleury, São Paulo, Brazil.

Handbook of Clinical Neurology
|September 25, 2024
PubMed
Summary
This summary is machine-generated.

Toxic-metabolic encephalopathies cause brain damage from toxins. This review details acquired leukoencephalopathies, focusing on imaging for diagnosis and prognosis.

Keywords:
Drug-related toxic leukoencephalopathyLeukoencephalopathiesMetabolic diseasesNeurotoxicityToxic–metabolic encephalopathy

More Related Videos

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

29.9K
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K

Related Experiment Videos

Last Updated: Jun 12, 2025

Isolation of Brain-infiltrating Leukocytes
06:44

Isolation of Brain-infiltrating Leukocytes

Published on: June 13, 2011

19.1K
Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

29.9K
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K

Area of Science:

  • Neurology
  • Toxicology
  • Radiology

Background:

  • Toxic-metabolic encephalopathies are a significant cause of acute encephalopathy.
  • Symptoms can be nonspecific, and toxicologic tests may be limited.
  • Imaging is crucial for diagnosis and prognosis in these conditions.

Purpose of the Study:

  • To review acquired toxic-metabolic leukoencephalopathies.
  • To discuss their pathophysiology and characteristic imaging patterns.
  • To provide a rationale for accurate diagnosis.

Main Methods:

  • Review of acquired toxic-metabolic leukoencephalopathies.
  • Detailed commentary on pathophysiology.
  • Analysis of imaging patterns and diagnostic rationale.

Main Results:

  • Acquired toxic-metabolic leukoencephalopathies present diverse pathophysiologies.
  • Specific imaging findings aid in differential diagnosis.
  • Imaging guides further investigations and offers prognostic insights.

Conclusions:

  • Understanding imaging patterns is key for diagnosing toxic-metabolic leukoencephalopathies.
  • Early and accurate diagnosis through imaging improves patient outcomes.
  • This review provides a framework for interpreting neuroimaging in toxic encephalopathy.